1. In vitro effects of FBXW7 mutation in serous endometrial cancer: Increased levels of potentially druggable proteins and sensitivity to SI-2 and dinaciclib
    Mary Ellen Urick et al, 2018, Molecular Carcinogenesis CrossRef
  2. Linked-read Sequencing Analysis Reveals Tumor-specific Genome Variation Landscapes in Neurofibromatosis Type 2 (NF2) Patients
    Daniel S. Roberts et al, 2019, Otology & Neurotology CrossRef
  3. Downregulation of specific FBXW7 isoforms with differential effects in T-cell lymphoblastic lymphoma
    Irene Vázquez-Domínguez et al, 2019, Oncogene CrossRef
  4. FBXW7 in Cancer: What Has Been Unraveled Thus Far?
    Bethsebie Lalduhsaki Sailo et al, 2019, Cancers CrossRef
  5. New Challenges in Tumor Mutation Heterogeneity in Advanced Ovarian Cancer by a Targeted Next-Generation Sequencing (NGS) Approach
    Marica Garziera et al, 2019, Cells CrossRef
  6. Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy
    Huiying Han et al, 2019, Cancer Cell CrossRef
  7. Loss of Fbxw7 in Sertoli cells impairs testis development and causes infertility in mice†
    Hanbin Zhang et al, 2019 CrossRef
  8. Trametinib potentiates TRAIL‐induced apoptosis via FBW7‐dependent Mcl‐1 degradation in colorectal cancer cells
    Lin Lin et al, 2020, J Cell Mol Med CrossRef
  9. Synaptic Protein Degradation Controls Sexually Dimorphic Circuits through Regulation of DCC/UNC-40
    Yehuda Salzberg et al, 2020, Current Biology CrossRef
  10. FBXW7alpha Promotes the Recovery of Traumatic Spinal Cord
    Hong Zhang et al, 2020, CMM CrossRef
  11. Putative E3 ligases as candidates controlling BRASSINOSTEROID INSENSITIVE 2 (BIN2) kinase in Arabidopsis
    Yu Jeong Jeong, 2020, Plant Biotechnol Rep CrossRef
  12. The Tumor Suppressor FBW7 and the Vitamin D Receptor Are Mutual Cofactors in Protein Turnover and Transcriptional Regulation
    Reyhaneh Salehi-Tabar et al, 2019, Mol Cancer Res CrossRef
  13. Turning Up the Heat on MYC: Progress in Small-Molecule Inhibitors.
    Mihai I Truica et al, 2021, Cancer Res CrossRef
  14. The FBXW7‐NOTCH interactome : A ubiquitin proteasomal system‐induced crosstalk modulating oncogenic transformation in human tissues
    Rohan Kar et al, 2021, Cancer Reports CrossRef
  15. MicroRNA-25 Exerts an Oncogenic Function by Regulating the Ubiquitin Ligase Fbxw7 in Hepatocellular Carcinoma
    Hatem El-mezayen et al, 2021, Ann Surg Oncol CrossRef
  16. Emerging role of ubiquitination/deubiquitination modification of PD-1/PD-L1 in cancer immunotherapy
    Peng Ding et al, 2022, Genes & Diseases CrossRef
  17. E3 ubiquitin ligase FBXW7 enhances radiosensitivity of non-small cell lung cancer cells by inhibiting SOX9 regulation of CDKN1A through ubiquitination
    Hongge Zhu et al, 2022, Lab Invest CrossRef
  18. The E3 Ligases in Cervical Cancer and Endometrial Cancer
    Fengguang Zhai et al, 2022, Cancers CrossRef
  19. The Role of FBXW7 in Gynecologic Malignancies
    Riccardo Di Fiore et al, 2023, Cells CrossRef
  20. Degradation of MYC by the mutant p53 reactivator drug, COTI-2 in breast cancer cells
    Minhong Tang et al, 2023, Invest New Drugs CrossRef
  21. FBXW7 and human tumors: mechanisms of drug resistance and potential therapeutic strategies
    Wanqing Wang et al, 2023, Front. Pharmacol. CrossRef
  22. Canagliflozin treatment prevents follicular exhaustion and attenuates hallmarks of ovarian aging in genetically heterogenous mice
    José V. V. Isola et al, 2024, GeroScience CrossRef
  23. Characteristics of genomic alterations and heavy metals in hypertensive patients with non‑small cell lung cancer
    Xinbo Zhang et al, 2025, Oncol Lett CrossRef